Trials / Completed
CompletedNCT00720057
Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain.
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Trial Assessing the Analgesic Efficacy of a Single, Oral Dose of an Extended Release Naproxen Sodium Tablet in Postsurgical Dental Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 312 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 16 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the analgesic efficacy of a single, oral dose of a naproxen sodium extended-release tablet, compared to placebo in postsurgical dental pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naproxen Sodium ER (BAYH6689) | Analgesic efficacy in dental pain; per oral; 1 tablet extended release Naproxen Sodium; with a full glass of water within 4 hours post surgery |
| DRUG | Placebo | Inactive ingredient; per oral; 1 lactose based tablet; with a full glass of water within 4 hours post surgery |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-07-22
- Last updated
- 2015-08-25
- Results posted
- 2011-01-25
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00720057. Inclusion in this directory is not an endorsement.